{"filings":[{"id":863476,"accession_number":"0001193125-26-257764","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2026-06-04T21:20:55+00:00","items":["5.07"],"status":"ready","headline":"Arteris holds annual meeting; elects three directors and ratifies Deloitte as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders elected Antonio J. Viana, Wayne C. Cantwell, and Joachim Kunkel as Class II directors for three-year terms.","Votes for Viana: 24,909,978; Cantwell: 26,200,856; Kunkel: 27,178,951; broker non-votes 3,126,251.","Ratification of Deloitte & Touche as independent auditor for FY 2026: 36,095,687 for, 145,040 against, 9,284 abstentions.","Record date April 9, 2026; 46,092,618 shares outstanding entitled to vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":40362,"accession_number":"0001628280-26-034102","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2026-05-12T20:08:56+00:00","items":["2.02","9.01","5.02"],"status":"ready","headline":"Arteris Q1 revenue $22.9M (+39% YoY); CFO Nick Hawkins to retire Aug 31","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $22.9M (+39% YoY); ACV plus royalties $92.8M (+39% YoY).","Net loss $8.0M ($0.17 per share); Non-GAAP net loss $1.2M ($0.03 per share).","CFO Nick Hawkins retiring effective Aug 31, 2026 due to family illness; will advise transition.","RPO $118.3M (+33% YoY); trailing 12-month royalties $7.9M (+67% YoY)."],"consensus_eps_estimate":-0.0707,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":22936000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107000,"accession_number":"0001628280-26-007669","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q4 2025 revenue $20.1M (+30% YoY); ACV+royalties record $83.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $20.1M (+30% YoY); full-year revenue $70.6M (+22% YoY).","Record ACV+royalties $83.6M (+28% YoY); RPO $116.8M (+32% YoY).","Q4 GAAP net loss $0.19/shr; Non-GAAP net loss $0.05/shr. Full-year GAAP loss $0.82/shr; Non-GAAP $0.33/shr.","Royalties grew 50% YoY to $6.6M; positive non-GAAP free cash flow $3.0M in Q4.","Closed Cycuity acquisition in Jan 2026; NXP expanded use of Arteris IP across AI solutions."],"consensus_eps_estimate":-0.0682,"consensus_eps_actual":-0.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":70579000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123346,"accession_number":"0001193125-25-315992","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2025-12-11T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Arteris agrees to acquire Cycuity for up to $45M in cash and stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration up to $45M: $13.5M cash + $19.5M stock at closing, plus up to $12M earnout based on 2026 bookings milestones.","Acquisition structured as two-step merger: First Merger Sub I merges into Cycuity, then Cycuity merges into Merger Sub II, becoming wholly-owned subsidiary.","Closing subject to Cycuity stockholder approval, no legal prohibition, accuracy of reps, and absence of material adverse effect.","Indemnity escrow of $3.3M in cash/stock for 12 months; adjustment escrow of $330K cash for purchase price adjustments.","Arteris to issue shares based on 30-day VWAP with collar; certain holders receive cash instead of stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123345,"accession_number":"0001628280-25-048868","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q3 revenue $17.4M (+18% YoY); ACV+royalties $74.9M (+24%); RPO tops $100M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Revenue $17.4M (+18% YoY); GAAP operating loss $8.7M vs $7.9M YoY.","Non-GAAP net loss $0.09/sh; positive free cash flow $2.5M (14% of revenue).","ACV+royalties $74.9M (+24% YoY); RPO $104.7M (+34%), first time above $100M.","New license wins: Altera expanded, AMD ordered additional, automotive & aerospace customers.","Provided estimated Q4 and updated FY2025 guidance (specific figures not in release snippet)."],"consensus_eps_estimate":-0.0942,"consensus_eps_actual":-0.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":50442000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140016,"accession_number":"0001667011-25-000028","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q2 revenue up 13% YoY to $16.5M; record ACV+royalties $69.1M","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Revenue $16.5M (+13% YoY); ACV+royalties $69.1M (record, +15% YoY).","RPO $99.3M (+28% YoY); GAAP operating loss $8.2M vs $7.4M loss year ago.","Non-GAAP operating loss flat at $3.5M; net loss $9.1M ($0.22 per share).","Business highlights: AMD licensed FlexGen IP; multi-die solution expanded with UCIe, Arm, RISC-V."],"consensus_eps_estimate":-0.0972,"consensus_eps_actual":-0.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":33034000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157629,"accession_number":"0001193125-25-137147","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Arteris stockholders elect Janac and Raza as Class I directors, ratify Deloitte as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["K. Charles Janac re-elected with 27,307,847 votes for, 107,614 withheld; 4,325,257 broker non-votes.","S. Atiq Raza re-elected with 24,112,098 votes for, 3,303,363 withheld; 4,325,257 broker non-votes.","Ratification of Deloitte & Touche as auditor: 31,548,805 for, 131,865 against, 60,048 abstentions; no broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157628,"accession_number":"0001667011-25-000018","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q1 revenue $16.5M (+28% YoY); ACV+royalties record $66.8M; free cash flow positive $2.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $16.5M, up 28% YoY; ACV+royalties $66.8M (record, +15% YoY).","GAAP operating loss $7.7M vs $9.1M YoY; non-GAAP operating loss $3.2M vs $5.3M.","Non-GAAP free cash flow positive $2.7M (16% of revenue); net loss $8.1M ($0.20/sh).","Business: added 4 top-30 tech companies licenses, new automotive OEM, Nextchip chose FlexNoC for ADAS.","Joined Intel Foundry Accelerator; opened engineering center in Krakow, Poland."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":16532000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175999,"accession_number":"0001193125-25-066596","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Isabelle F. Geday resigns from Arteris board; RSUs accelerated","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Resignation effective March 27, 2025, for personal reasons, not due to any disagreements with the Company.","Board approved accelerated vesting of 19,287 RSUs granted under 2024 Non-Employee Director Compensation Policy.","RSUs would have vested on June 4, 2025, or at the 2025 annual meeting, whichever earlier.","Ms. Geday had served on the Board since 2020."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175998,"accession_number":"0001667011-25-000009","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q4 revenue $15.5M (+24% YoY); ACV+royalties record $65.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2024 revenue $57.7M (+8% YoY); net loss $33.6M ($0.86/share).","Q4 GAAP net loss $8.2M ($0.20/share); non-GAAP net loss $3.9M ($0.10/share).","Record ACV plus royalties $65.1M (+16% YoY); RPO $88.4M (+22% YoY).","Signed 14 new customers in 2024, including Infineon and two major automotive OEMs.","Guidance for Q1 and full year 2025 was provided but specific figures not detailed in release."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.86,"consensus_revenue_estimate":null,"consensus_revenue_actual":57724000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192911,"accession_number":"0001667011-24-000035","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris reports Q3 2024 revenue of $14.7M, record ACV+royalties of $60.5M, and positive free cash flow","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $14.7 million; ACV plus royalties hit a record $60.5M, up 6% YoY.","RPO of $78.4 million, up 25% YoY, the highest ever reported.","Operating loss improved to $7.9M from $8.5M a year ago; non-GAAP operating loss narrowed to $3.3M.","Non-GAAP free cash flow positive for third consecutive quarter at $1.1M (7% of revenue).","Expanded customer adoption: top 5 tech company expanding AI SoC deployment, majority of license dollars from top 30 global tech firms, and new focus on microcontrollers."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":42235000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209306,"accession_number":"0001193125-24-219580","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2024-09-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Arteris appoints Joachim Kunkel, former Synopsys IP GM, to board effective Sept 16","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Joachim Kunkel as Class II director and Compensation Committee member, effective Sept 16, 2024.","Kunkel was General Manager of Synopsys' IP business unit from 2006 until recently.","Kunkel will receive a $57,500 annual retainer (prorated) and an initial RSU award valued at $300,000.","Kunkel co-founded CADIS GmbH and holds an M.S.E.E. from Aachen University of Technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209305,"accession_number":"0001667011-24-000024","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q2 2024: revenue $14.6M (+13% seq), record ACV $60.1M, net loss $0.22/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $14.6M, up 13% sequentially; ACV+TTM variable royalties $60.1M (+3% YoY); RPO $77.5M (+19% YoY).","GAAP net loss $8.3M ($0.22/share); non-GAAP net loss $4.4M ($0.11/share).","Non-GAAP free cash flow positive $0.3M (1.8% of revenue), second consecutive quarter positive.","Added seven new customers in automotive, AI, and enterprise computing; included two global automotive OEMs.","Esperanto Technologies and Andes Technology partnership highlighted; AIP added to Russell 2000 index."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":27522000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227278,"accession_number":"0001193125-24-155149","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Arteris annual meeting elects three Class III directors and ratifies auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected directors: Raman K. Chitkara (24.2M for), Isabelle F. Geday (22.4M for), Claudia Fan Munce (22.3M for).","Ratified Deloitte & Touche as independent auditor for FY2024 with 28.9M votes for, 176.7K against, 275.2K abstentions.","No other proposals voted on; 38.4M shares outstanding and entitled to vote as of record date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227277,"accession_number":"0001667011-24-000015","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q1 revenue $12.9M, ACV up 6% to $58.2M, net loss $9.4M; positive free cash flow","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $12.9M; ACV+TTM royalties $58.2M (+6% YoY); RPO $74.7M (+30% YoY).","Net loss $9.4M ($0.25/share); Non-GAAP net loss $5.6M ($0.15/share).","Positive free cash flow $0.3M (2.2% of revenue); Non-GAAP operating loss $5.3M.","Five deals with top-30 tech firms; half of license deals enabled AI/ML design starts."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":12947000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246158,"accession_number":"0001667011-24-000009","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2024-02-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris reports Q4 revenue $12.5M (+12% YoY); ACV hits $56.1M above guidance","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 revenue $12.5M (+12% YoY); FY revenue $53.7M (+7% YoY).","Annual Contract Value + TTM variable royalties $56.1M (+7% YoY), above high-end of guidance.","Q4 GAAP net loss $10.5M ($0.29/sh); non-GAAP net loss $6.8M ($0.18/sh).","Added 23 net new Active Customers in 2023; 29 design starts in Q4 including 9 AI/ML.","Provided Q1 and FY2024 guidance (specific figures not included in excerpt)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":53666000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":263611,"accession_number":"0001667011-23-000028","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q3 revenue $13.3M (+5% YoY); ACV+royalties $57.3M (+8%); guides Q4 rev $11.3-12.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["ACV+TTM royalties $57.3M, up 8% YoY; net loss $8.2M ($0.23/share); non-GAAP net loss $4.2M ($0.12/share).","Revenue $13.3M (+5% YoY); operating loss $8.5M (63.7% of revenue); non-GAAP operating loss $4.5M.","Q4 guidance: revenue $11.3-12.3M; ACV+TTM royalties $52-56M; non-GAAP op loss 56.1%-76.1% of revenue.","RPO of $62.5M; 22 design starts in Q3 (12 AI-enabled); secured top-10 global fabless semiconductor customer.","FlexNoC 5 closed 9 deals since Q2 2023 release; NeuReality, AlChip, Fraunhofer partnerships announced."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":41162000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":280823,"accession_number":"0001667011-23-000021","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q2 revenue $14.7M beats guidance; ACV+TTM royalties +13% YoY; Q3 rev guide $12.5-13.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $14.7M exceeded guidance; ACV+TTM royalties $58.2M (+13% YoY, +21% ex-DJI).","GAAP net loss $9.2M ($0.26/share); non-GAAP net loss $4.7M ($0.13/share); non-GAAP op loss $4.2M.","Q3 guidance: revenue $12.5-13.5M, ACV+TTM $57-61M, non-GAAP op loss margin 42-62%.","Added 12 active customers; 22 design starts (12 AI-enabled); deals with three top-10 semis.","Majority of revenue contracts expected to be recognized ratably going forward."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":27888000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299465,"accession_number":"0001193125-23-163484","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2023-06-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Arteris annual meeting elects two directors and ratifies Deloitte as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Wayne C. Cantwell elected with 23,595,430 votes for, 89,614 withheld; 3,210,355 broker non-votes.","Antonio J. Viana elected with 20,482,543 votes for, 3,202,501 withheld; 3,210,355 broker non-votes.","Deloitte & Touche ratified as independent auditor for FY 2023 with 26,887,877 votes for, 5,741 against, 1,781 abstentions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299464,"accession_number":"0001667011-23-000017","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Arteris and Jefferies mutually terminate $50M ATM equity offering agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mutual termination of Sale Agreement dated Nov 8, 2022.","Agreement allowed for up to $50M in at-the-market sales of common stock.","No shares of common stock were sold under the terminated agreement.","Termination effective May 4, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299463,"accession_number":"0001667011-23-000014","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2023-05-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q1 revenue $13.2M (+12% YoY); net loss $0.26/share; guides FY rev $56-60M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $13.2M (+12% YoY); ACV+TTM royalties $54.8M (+4% YoY).","GAAP net loss $9.0M ($0.26 EPS); Non-GAAP net loss $5.8M ($0.17 EPS).","22 new design starts, 6 new customers; Tenstorrent and ASICLAND IP licenses.","Q2 2023 guidance: rev $13.0-$14.0M; FY 2023 rev $56.0-$60.0M.","Non-GAAP operating loss 42.4% of revenue; free cash flow -$8.5M (65% of rev)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":13154000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319614,"accession_number":"0001193125-23-080854","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2023-03-28T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Arteris dismisses Moss Adams as auditor, engages Deloitte & Touche for FY2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee dismissed Moss Adams LLP effective March 23, 2023.","No disagreements or reportable events in audits for years ended Dec 31, 2021 and 2022.","Deloitte & Touche LLP engaged as independent auditor for FY2023, effective immediately.","Moss Adams provided a letter to the SEC, filed as Exhibit 16.1, agreeing with disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319613,"accession_number":"0001667011-23-000006","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris reports FY2022 revenue up 33% to $50.4M; net loss $27.4M; guides FY2023 revenue $56-60M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2022 revenue $50.4M (+33% YoY); net loss $27.4M ($0.84/share); non-GAAP net loss $14.7M ($0.45/share).","Q4 2022 revenue $11.2M (-2% YoY); net loss $7.2M ($0.21/share); non-GAAP net loss $4.0M ($0.12/share).","ACV+TTM royalties $52.4M (+22% YoY adjusted for HiSilicon/DJI loss); RPO $57.7M (-5% YoY).","Guides Q1 2023 revenue $11-13M; FY2023 revenue $56-60M; non-GAAP operating loss 28.5%-43.5% of revenue.","Acquired Semifore in Q4; launched FlexNoC 5; added 38 active customers in FY2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":50378000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":337812,"accession_number":"0001667011-22-000035","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2022-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q3 revenue $12.6M up 41% YoY; ACV+TTM royalties $53.2M up 17%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $12.6M (up 41% YoY); ACV+TTM royalties $53.2M (up 17% YoY).","Net loss $7.7M ($0.23/share); Non-GAAP net loss $4.2M ($0.13/share).","Added 10 active customers including major EV manufacturer and space customer.","Guidance: Q4 revenue $10.8-$11.8M; FY2022 revenue $50-$51M.","Strengthened management with new EVP Global Sales; milestone of 3B systems shipped."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":39175000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355176,"accession_number":"0001667011-22-000026","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2022-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q2 revenue $14.8M (+37% YoY); ACV+royalties $51.7M, guides Q3 rev $10.5-12.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $14.8M up 37% YoY; ACV + TTM royalties $51.7M up 18% YoY.","GAAP net loss $5.7M ($0.18/sh); non-GAAP net loss $2.2M ($0.07/sh).","Q3 guidance: rev $10.5-12.5M, non-GAAP op loss 41.2%-56.2%; FY rev $49.5-52.5M.","Added 9 customers including Telechips, Pliops, Sunrise Memory, a leading automotive OEM and hyperscaler.","Claudia Fan Munce, former IBM executive, appointed to Board of Directors."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":26577000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373282,"accession_number":"0001193125-22-176479","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2022-06-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Arteris stockholders elect Class I directors and ratify Moss Adams as auditor at 2022 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["S. Atiq Raza and K. Charles Janac elected as Class I directors with 20,064,693 and 20,067,420 votes for, respectively.","Broker non-votes of 930,392 shares on director election.","Ratification of Moss Adams as independent auditor passed: 22,751,727 for, 16,002 against, 2,297 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373281,"accession_number":"0001667011-22-000018","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q1 revenue $11.8M (+77% YoY); ACV+TTM royalties $52.8M (+26%); guides Q2 rev $11.5-14.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $11.8M (+77% YoY); GAAP net loss $6.8M ($0.22/share); non-GAAP net loss $4.4M ($0.14/share).","ACV+TTM royalties $52.8M (+26% YoY); RPO $60.5M (+28% YoY).","Operating loss $6.6M (56% of revenue); non-GAAP op. loss $4.2M (36% of revenue).","Q2 guidance: ACV+TTM royalties $49.5-51.5M, revenue $11.5-14.5M; FY22 revenue $48-52M.","19 design starts in Q1; added 7 active customers; BMW licensed Arteris IP for neural network accelerator."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":11755000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373280,"accession_number":"0001193125-22-096324","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2022-04-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Arteris appoints Claudia Fan Munce to board; Christian Claussen not standing for reelection","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased from 7 to 8; Claudia Fan Munce appointed effective May 1, 2022 as Class III director and NCG Committee member.","Munce is Venture Advisor at NEA and former Managing Director at IBM Venture Capital Group; also serves on Best Buy and Bank of the West boards.","Non-employee director compensation: $55,000 annual retainer (pro-rated) plus initial RSU award of $300,000 based on 30-day average stock price.","Christian Claussen will not stand for reelection at June 14, 2022 annual meeting; departure not due to any disagreement with the Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":392025,"accession_number":"0001667011-22-000005","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2022-03-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q4 revenue $11.4M, FY21 revenue $37.9M (+19% YoY); guides FY22 rev $47-51M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2021 revenue $11.4M; full-year 2021 revenue $37.9M, up 19% YoY.","Q4 GAAP net loss $7.8M ($0.27/share); non-GAAP net loss $3.3M ($0.12/share).","ACV + TTM royalties $50.0M (+19% YoY); RPO $60.5M (+26% YoY).","Active customers 192 at year-end (+28% YoY); added 13 customers in Q4.","FY 2022 revenue guidance $47-51M; Q1 2022 revenue guidance $10-12M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":392024,"accession_number":"0001193125-22-048508","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2022-02-22T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Arteris subsidiary invests in Transchip via technology license and cash; post-money valuation ~$35.6M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["AHK will contribute RMB 77.33M via technology license and RMB 1.7M cash, plus transfer of initial capital, for 40.321% of Transchip.","Third-party investors (SME, Luojia, Guinie) contribute RMB 76.5M (~$12M) cash for combined 38.931%.","Management Co subscribes RMB 40.77M (20.748%) for employee option plan; total capital rises to RMB 196.5M.","Technology license from AHK to Transchip covers FlexNoC, FlexWay, CodaCache, Ncore, and Resilience/AI for 5-year design term.","AHK gets one of three board seats; proceeds to fund product development using licensed technologies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410344,"accession_number":"0001193125-21-353839","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2021-12-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Arteris raises CEO and CFO base salaries and target bonuses; director Geday transitions to consultant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Janac base salary to $370,000 from $315,100, effective Nov 1, 2021; CFO Hawkins to $313,200 from $293,200.","Janac's target bonus increased to 92% of base salary from 35%, and Hawkins' to 52% from 35%, effective Jan 1, 2022.","Director Isabelle Geday transitions to consultant role effective Dec 1, 2021 with three-year consulting agreement.","Geday to receive $26,445 monthly for first 12 months, then $19,445 monthly for remaining 24 months.","Geday remains eligible for Non-Employee Director Compensation Program as a board member."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410343,"accession_number":"0001667011-21-000007","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2021-11-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arteris Q3 revenue up 39% YoY to $9.0M; guides Q4 $10-11.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $9.0M (+39% YoY); net loss $5.0M ($0.24 per share); non-GAAP net loss $4.4M ($0.21).","ACV+TTM royalties $45.6M (+21%); RPO $50.6M (+48% YoY).","Active customers 179 (+72%), design starts 22 (+69%).","Q4 guidance: revenue $10.0-11.1M; FY2021 revenue $36.3-37.5M.","IPO gross proceeds $80.5M from overallotment exercise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410342,"accession_number":"0001193125-21-313553","cik":1667011,"company_name":"Arteris, Inc.","ticker":"AIP","form_type":"8-K","filed_at":"2021-10-29T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Arteris completes IPO of 5.75M shares at $14.00; gross proceeds $80.5M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed IPO of 5,750,000 shares at $14.00 per share, including full exercise of underwriters' option.","Gross proceeds of $80.5 million before underwriting discounts and offering expenses.","Amended charter and bylaws effective upon IPO closing: classified board, exclusive forum provisions, elimination of stockholder right to call special meetings or act by written consent.","Authorized capital: 300M shares common stock, 10M shares undesignated preferred stock; supermajority vote required for certain amendments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":1735609349.2648757,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}